2012
DOI: 10.1016/j.neuron.2011.10.038
|View full text |Cite
|
Sign up to set email alerts
|

Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 Agonism

Abstract: Summary We identified subsets of neurons in the brain that co-express the dopamine receptor subtype-2 (DRD2) and the ghrelin receptor (GHSR1a). Combination of FRET confocal microscopy and Tr-FRET established the presence of GHSR1a:DRD2 heteromers in hypothalamic neurons. To interrogate function, mice were treated with the selective DRD2 agonist cabergoline which produced anorexia in wild-type and ghrelin−/− mice; intriguingly, ghsr−/− mice were refractory illustrating dependence on GHSR1a, but not ghrelin. Elu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

11
304
3
16

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 282 publications
(334 citation statements)
references
References 53 publications
11
304
3
16
Order By: Relevance
“…1C). Molecule size cutoff was below 70 kDa, with a step-like decrease in permeability rate between 20 and 40 kDa ( To investigate the transfer rate of ghrelin (3.3 kDa), a recently developed bioactive fluorescently labeled ghrelin derivative (3.8 kDa), capable of specifically binding and activating growth hormone secretagogue receptor-1a (GHS-R-1a) (19,20), was used. The extravasation rate of fluorescent ghrelin across the ME capillary barrier was comparable to that of 4-kDa FITC-conjugated dextran (∼0.8 μm/s) ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…1C). Molecule size cutoff was below 70 kDa, with a step-like decrease in permeability rate between 20 and 40 kDa ( To investigate the transfer rate of ghrelin (3.3 kDa), a recently developed bioactive fluorescently labeled ghrelin derivative (3.8 kDa), capable of specifically binding and activating growth hormone secretagogue receptor-1a (GHS-R-1a) (19,20), was used. The extravasation rate of fluorescent ghrelin across the ME capillary barrier was comparable to that of 4-kDa FITC-conjugated dextran (∼0.8 μm/s) ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Further support for a role of GHS‐R1A in reward regulation is the human genetic data showing that a single nucleotide polymorphism in the GHS‐R1A gene is associated with high alcohol consumption in humans (Landgren et al., 2008). Given that GHS‐R1A has been shown to alter the sensitivity of the mesolimbic dopamine system via its ability to heterodimerize with dopamine D1‐ and D2‐like receptors (Jiang et al., 2006; Kern et al., 2012) as well as via its constitutive activity (Holst et al., 2003), we hypothesize that ventral tegmental GHS‐R1A are important for reward processes and for development of alcohol use disorder. Given that ghrelin is an orexigenic peptide and that alcohol contains calories, it should be considered that the ability of GHS‐R1A antagonists to reduce alcohol intake is due to interference with alcohol's calorific value and rather than its rewarding properties.…”
Section: Discussionmentioning
confidence: 99%
“…This aspect is presently the subject of intense research (see Guidolin et al, 2015;Borroto-Escuela et al, 2017;Farran, 2017, for recent reviews). In recent years, such an effort allowed the characterization of a panel of receptor complexes representing possible targets for the treatment of pathologic conditions, such as Parkinson's disease , schizophrenia and depression Sahlholm et al, 2017), neuropathic pain , addiction (Gomes et al, 2013), and food intake disorders (Kern et al, 2012). On this basis, novel strategies for drug treatment have also been proposed.…”
Section: Introductionmentioning
confidence: 99%